DrugRisk Center: Experts Renew Pradaxa Concerns Despite FDA Announcement

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Denver, CO (PRWEB) December 06, 2012 The DrugRisk Resource Center is alerting patients taking the blood thinner Pradaxa that health experts continue to disagree about the safety of the drug and its propensity to cause dangerous or fatal internal bleeding. Last month, the FDA updated its warnings to say that, for now, testing shows Pradaxa carries the same risks as warfarin and Coumadin.* However, the New York Times published a
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations